The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
Abstract Osteosarcoma is the most common primary malignant bone tumor, and its standard treatment is a combination of surgery and chemotherapy. A poor response to chemotherapy causes unfavorable oncological outcomes. We investigated the correlation between osteoclast differentiation in biopsy specim...
Main Authors: | Y. Araki, N. Yamamoto, K. Hayashi, A. Takeuchi, S. Miwa, K. Igarashi, T. Higuchi, K. Abe, Y. Taniguchi, H. Yonezawa, S. Morinaga, Y. Asano, H. Ikeda, T. Nojima, H. Tsuchiya |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80504-w |
Similar Items
-
Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
by: Yoshihiro Araki, et al.
Published: (2021-04-01) -
Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature
by: Yoshihiro Araki, et al.
Published: (2021-01-01) -
Clinical outcomes of frozen autograft reconstruction for the treatment of primary bone sarcoma in adolescents and young adults
by: Yoshihiro Araki, et al.
Published: (2021-08-01) -
Diagnosis and treatment of intramedullary osteosclerosis: a report of three cases and literature review
by: Kensaku Abe, et al.
Published: (2020-11-01) -
Case Report: Unresectable pulmonary metastases of a giant cell tumor of bone treated with denosumab: a case report and review of literature
by: Shinji Miwa, et al.
Published: (2023-08-01)